Sign inJoin waitlistJoin the waitlist

Brandon Hayes-Lattin

Medical Director of the OHSU Knight Cancer Institute’s Adolescent and Young Adult (AYA) Oncology Program · Oregon Health & Science University

Credentials: · · · ·

History

OHSU Knight Cancer Institute’s Adolescent and Young Adult (AYA) Oncology Program Center · Oregon Health & Science University
Present
Medicine Division · Oregon Health & Science University
Present
AYA Oncology Program · Clinical Center at the National Institutes of Health
Present

Hematology and Medical Oncology
Oregon Health & Science University
2001–2004
Oregon Health & Science University
2000–2001
Internal Medicine
Oregon Health & Science University
1997–2000
University of Washington School of Medicine
1993–1997
Stanford University
1988–1992

Research

The distinctive biology of cancer in adolescents and young adults
Review · Nature reviews. Cancer · 2008 · 531 citations
Identifying and addressing the needs of adolescents and young adults with cancer: summary of an Institute of Medicine workshop
Review · The Oncologist · 2015 · 248 citations
Next steps for adolescent and young adult oncology workshop: An update on progress and recommendations for the future
Review · Cancer · 2016 · 213 citations

Richard Maziarz
28 papers
JL
Jessica Leonard
14 papers · 3 as a fellow
Mary Horowitz
12 papers
Bronwen Shaw
10 papers
GM
Gabrielle Meyers
10 papers
BB
Brian Bolwell
9 papers
Hillard Lazarus
9 papers
Leanne Embry
9 papers
WB
Werner Bleyer
8 papers
David Freyer
7 papers
ET
Elie Traer
7 papers
GH
Gregory Hale
7 papers

Clinical trials

Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Principal investigator · Terminated · Phase 2
OHSU Knight Cancer Institute
2009–2014
Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery
Study chair · Terminated · Phase 2
OHSU Knight Cancer Institute
2005–2006
Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy
Study chair · Withdrawn · Phase 2
OHSU Knight Cancer Institute
2005–2008
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2017–2027